COSMIC Principle Investigators (Beneficiaries)

Prof. dr. Antoine van Kampen

Professor Medical Bionformatics at the Academic Medical (AMC) Center, Amsterdam. My research focuses on bioinformatics and systems medicine.

Dr. Jeroen Guikema

Dr. Jeroen Guikema

Deputy Coordinator & Work Pacakge 3 (BCN) leader; Beneficiary (B1c)

Assistant professor at the department of pathology, Academic Medical Center (AMC), Amsterdam. My research focusses on Ig gene recombinations in B cells.

Dr. Niek de Vries

Dr. Niek de Vries

Beneficiary (B1b)

Associate Professor of Clinical Immunology & Rheumatology, Academic Medical Center (AMC), Amsterdam. My research focuses on adaptive immune responses in immune-mediated inflammatory disease.

Dr. Olivier Gandrillon

Dr. Olivier Gandrillon

Beneficiary (B2)

Group leader DRACULA team, Research Centre Inria, Lyon. My research focuses on multiscale modelling of cell dynamics with application to hematopoiesis.

Dr. Fabien Crauste

Dr. Fabien Crauste

Beneficiary (B2)

Inria DRACULA team, Inria Research Centre, Lyon. My research focuses on computational immunology and multiscale modelling of cell proliferation and differentiation.

Prof. dr. Rikard Holmdahl

Prof. dr. Rikard Holmdahl

Work package 4 (RA) leader; Beneficiary (B3)

Professor of Chronic Inflammatory Disorders (CID), Karolinska Institute, Stockholm. My research focuses on understanding the development of CID.

Dr. Martin Turner

Dr. Martin Turner

Beneficiary (B4)

Head of Lymphocyte Signalling, Babraham Institute, Cambridge. My research focuses on RNA-binding proteins and MicroRNAs and how these function within signal transduction networks and DNA transcription factor networks to control cell differentiation and immunity.

Dr. Stefano Casola

Dr. Stefano Casola

Beneficiary (B5)

Molecular oncologist and expert in the study of B-lymphocytes and lymphomas, Stefano Casola directs the unit of Genetics of B cells and lymphomas at the cancer research institute IFOM.

Dr. Judith Farrés

Dr. Judith Farrés

Beneficiary (B6)

Judith Farrés (Anaxomics Biotech project leader) is Head of Molecular Health and Project Management with experience in biochemistry and transfer of biological knowledge into computational models with artificial intelligence systems

Dr. Malin Hultqvist-Hopkins

CEO of Redoxis. I focus on preclinical drug development and efficacy evaluation in models of autoimmune diseases.

Prof. dr. Michael Meyer-Hermann

Prof. dr. Michael Meyer-Hermann

Workpackage 5 (Computational Modelling) leader; Beneficiary (B8)

Professor of Systems Immunology, the Helmholtz Centre for Infection Research, Braunschweig, Germany.

Dr. María Rodríguez Martínez

Research Staff Member at IBM, Zurich, Switzerland

Dr. Kostas Stamatopoulos

Dr. Kostas Stamatopoulos

Beneficiary (10)

Director of the Institute of Applied Biosciences at CERTH, the Center for Research and Technology Hella, Thessaloniki, Greece.

12456789103111213

 

Dr. Sebastian Binder

Dr. Sebastian Binder

Workpackage 5 (Computational Modelling); Beneficiary (B8)

Post-doc department of Systems Immunology (prof. dr. Michael Meyer-Hermann), the Helmholtz Centre for Infection Research, Braunschweig, Germany.

58
© 2017 COSMIC. All Rights Reserved.

Please publish modules in offcanvas position.